Recent development and application of magnetic nanoparticles for cell labeling and imaging

Mini-Reviews in Medicinal Chemistry

Volumn 10, Issue 3, 2010, Pages 194-203

  Zhang, Chao ^a   Liu, Tao ^a   Gao, Jining ^a   Su, Yongping ^a   Shi, Chunmeng ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Cell tracking; Cytotoxicity; Magnetic nanoparticles; Superparamagnetic iron oxide nanoparticles; Targeted imaging

Indexed keywords

FERUCARBOTRAN; FERUMOXSIL; FERUMOXYTOL; GREEN FLUORESCENT PROTEIN; MACROGOL; MAGNETIC NANOPARTICLE; SUCCIMER; SUPERPARAMAGNETIC IRON OXIDE; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE; UNCLASSIFIED DRUG; VSOP C184;

ATHEROSCLEROSIS; BACKACHE; CELL DIVISION; CELL LABELING; CELL THERAPY; CELL TRACKING; CYTOTOXICITY; DRUG COATING; DRUG DECOMPOSITION; DRUG SAFETY; DRUG SYNTHESIS; ENDOCYTOSIS; HEADACHE; HUMAN; HYDRODYNAMICS; HYDROPHOBICITY; IMAGING; INTERNALIZATION; MAGNETIC FIELD; MULTIPOTENT STEM CELL; NANOCHEMISTRY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTICLE SIZE; PLASMA HALF LIFE; RETICULOENDOTHELIAL SYSTEM; REVIEW; SIDE EFFECT; SURFACE PROPERTY; TRANSMISSION ELECTRON MICROSCOPY; URTICARIA; VASODILATATION;

EID: 79953752879     PISSN: 13895575     EISSN: 18755607     Source Type: Journal    
DOI: 10.2174/138955710791185073     Document Type: Review

References (87)

1. Zhu, J.; Zhou, L.; Xing, W. F. Tracking neural stem cells in patients with brain trauma. N. Engl. J. Med., 2006, 355, 2376-2378.
2. Wang, X.; Yang, L.; Chen, Z.G.; Shin, D.M. Application of nanotechnology in cancer therapy and imaging. CA Cancer J Clin., 2008, 58, 97-110.
3. Corot, C.; Robert, P.; Idee, J.M.; Port, M. Recent advances in iron oxide nanocrystal technology for medical imaging. Adv. Drug Deliv. Rev., 2006, 58, 1471-1504.
4. Jeong, U.; Teng, X.W.; Wang, Y.; Yang, H.; Xia, Y.N. Superparamagnetic colloids: controlled synthesis and niche applications Adv. Mater., 2007, 19, 33-60.
5. Jun, Y.W.; Seo, J.W.; Cheon, J. Nanoscaling laws of magnetic nanoparticles and their applicabilities in biomedical sciences. Acc. Chem. Res., 2008, 41, 179-189.
6. Tanimoto, A.; Kuribayashi, S. Application of superparamagnetic iron oxide to imaging of hepatocellular carcinoma. Eur. J. Radiol., 2006, 58, 200-2016.
7. Jun, Y.W.; Lee, J.H.; Cheon, J. Chemical design of nanoparticle probes for high-performance magnetic resonance imaging. Angew. Chem. Int. Ed. Engl., 2008, 47, 5122-5135.
8. Thorek, D.L.; Chen, A.K.; Czupryna, J.; Tsourkas, A. Superparamagnetic iron oxide nanoparticle probes for molecular imaging. Ann. Biomed. Eng., 2006, 34, 23-38.
9. Taupitz, M.; Wagner, S.; Schnorr, J.; Kravec, I.; Pilgrimm, H.; Bergmann-Fritsch, H.; Hamm, B. Phase I clinical evaluation of citrate-coated monocrystalline very small superparamagnetic iron oxide particles as a new contrast medium for magnetic resonance imaging. Invest. Radiol., 2004, 39, 394-405.
10. Shen, T.; Weissleder, R.; Papisov, M.; Bogdanov, A., Jr.; Brady, T.J. Monocrystalline iron oxide nanocompounds (MION): physicochemical properties. Magn. Reson. Med., 1993, 29, 599-604.
11. Laurent, S.; Forge, D.; Port, M.; Roch, A.; Robic, C.; Vander Elst, L.; Muller, R.N. Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem. Rev., 2008, 108, 2064-2110.
12. Molday, R.M., D. Immunospecific ferromagnetic iron-dextran reagents for the labeling and magnetic separation of cells. J. Immunol. Methods, 1982, 52, 353-367.
13. Berry, C.C.; Wells, S.; Charles, S.; Aitchison, G.; Curtis, A.S. Cell response to dextran-derivatised iron oxide nanoparticles post internalisation. Biomaterials, 2004, 25, 5405-5413.
14. Sun, S.; Zeng, H.; Robinson, D.B.; Raoux, S.; Rice, P.M.; Wang, S.X.; Li, G. Monodisperse MFe2O4 (M = Fe, Co, Mn) nanoparticles. J. Am. Chem. Soc., 2004, 126, 273-279.
15. Park, J.; An, K.; Hwang, Y.; Park, J.G.; Noh, H.J.; Kim, J.Y.; Park, J.H.; Hwang, N.M.; Hyeon, T. Ultra-large-scale syntheses of monodisperse nanocrystals. Nat. Mater., 2004, 3, 891-895.
16. Jun, Y.W.; Huh, Y.M.; Choi, J.S.; Lee, J.H.; Song, H.T.; Kim, S.; Yoon, S.; Kim, K.S.; Shin, J.S.; Suh, J.S.; Cheon, J. Nanoscale size effect of magnetic nanocrystals and their utilization for cancer diagnosis via magnetic resonance imaging. J. Am. Chem. Soc., 2005, 127, 5732-5733.
17. Xu, C.; Xu, K.; Gu, H.; Zheng, R.; Liu, H.; Zhang, X.; Guo, Z.; Xu, B. Dopamine as a robust anchor to immobilize functional molecules on the iron oxide shell of magnetic nanoparticles. J. Am. Chem. Soc., 2004, 126, 9938-9939.
18. Dubertret, B.; Skourides, P.; Norris, D.J.; Noireaux, V.; Brivanlou, A.H.; Libchaber, A. In vivo imaging of quantum dots encapsulated in phospholipid micelles. Science, 2002, 298, 1759-1762.
19. Gao, X.; Cui, Y.; Levenson, R.M.; Chung, L.W.; Nie, S. In vivo cancer targeting and imaging with semiconductor quantum dots. Nat. Biotechnol., 2004, 22, 969-976.
20. Hoehn, M.; Wiedermann, D.; Justicia, C.; Ramos-Cabrer, P.; Kruttwig, K.; Farr, T.; Himmelreich, U. Cell tracking using magnetic resonance imaging. J. Physiol., 2007, 584, 25-30.
21. Genove, G.; DeMarco, U.; Xu, H.; Goins, W.F.; Ahrens, E.T. A new transgene reporter for in vivo magnetic resonance imaging. Nat. Med., 2005, 11, 450-454.
22. Ros, P.R.; Freeny, P.C.; Harms, S.E.; Seltzer, S.E.; Davis, P.L.; Chan, T.W.; Stillman, A.E.; Muroff, L.R.; Runge, V.M.; Nissenbaum, M.A. Hepatic MR imaging with ferumoxides: a multicenter clinical trial of the safety and efficacy in the detection of focal hepatic lesions. Radiology, 1995, 196, 481-488.
23. Peng, X.H.; Qian, X.; Mao, H.; Wang, A.Y.; Chen, Z.G.; Nie, S.; Shin, D.M. Targeted magnetic iron oxide nanoparticles for tumor imaging and therapy. Int. J. Nanomed., 2008, 3, 311-321.
24. Schulze, E.; Ferrucci, J.T., Jr.; Poss, K.; Lapointe, L.; Bogdanova, A.; Weissleder, R. Cellular uptake and trafficking of a prototypical magnetic iron oxide label in vitro. Invest. Radiol., 1995, 30, 604-610.
25. Anzai, Y. Superparamagnetic iron oxide nanoparticles: nodal metastases and beyond. Top. Magn. Reson. Imaging, 2004, 15, 103-111.
26. Choi, H.S.; Liu, W.; Misra, P.; Tanaka, E.; Zimmer, J.P.; Itty, I. B.; Bawendi, M.G.; Frangioni, J.V. Renal clearance of quantum dots. Nat. Biotechnol., 2007, 25, 1165-1170.
27. Zhang, C.; Shi, CM. Superparamagnetic iron oxide nanoparticles for in vivo stem cell tracking. Exp. Hematol., 2009, 37(Suppl 1), 102.
28. Park, B.H.; Jung, J.C.; Lee, G.H.; Kim, T.J.; Lee, Y.J.; Kim, J.Y.; Kim, Y.W.; Jeong, J.H.; Chang, Y. Comparison of labeling efficiency of different magneticnanoparticles into stem cell. Colloids Surf. A: Physicochem. Eng. Aspects., 2008, 313-314, 145-149.
29. Brunner, T.J.; Wick, P.; Manser, P.; Spohn, P.; Grass, R.N.; Limbach, L.K.; Bruinink, A.; Stark, W.J. In vitro cytotoxicity of oxide nanoparticles: comparison to asbestos, silica, and the effect of particle solubility. Environ. Sci. Technol., 2006, 40, 4374-4381.
30. Petri-Fink, A.; Steitz, B.; Finka, A.; Salaklang, J.; Hofmann, H. Effect of cell media on polymer coated superparamagnetic iron oxide nanoparticles (SPIONs): colloidal stability, cytotoxicity, and cellular uptake studies. Eur. J. Pharm. Biopharm., 2008, 68, 129-137.
31. Bulte, J.W.; Douglas, T.; Witwer, B.; Zhang, S.C.; Strable, E.; Lewis, B.K.; Zywicke, H.; Miller, B.; van Gelderen, P.; Moskowitz, B.M.; Duncan, I.D.; Frank, J.A. Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells. Nat. Biotechnol., 2001, 19, 1141-1147.
32. Suh, J.S.; Lee, J.Y.; Choi, Y.S.; Yu, F.; Yang, V.; Lee, S.J.; Chung, C.P.; Park, Y.J. Efficient labeling of mesenchymal stem cells using cell permeable magnetic nanoparticles. Biochem. Biophys. Res. Commun., 2009, 379, 669-675.
33. Ma, H.L.; Xu, Y.F.; Qi, X.R.; Maitani, Y.; Nagai, T. Superparamagnetic iron oxide nanoparticles stabilized by alginate: pharmacokinetics, tissue distribution, and applications in detecting liver cancers. Int. J. Pharm., 2008, 354, 217-226.
34. Kim, S.H.; Lee, W.J.; Lim, H.K.; Park, C.K. SPIO-enhanced MRI findings of well-differentiated hepatocellular carcinomas: correlation with MDCT findings. Korean J. Radiol., 2009, 10, 112-20.
35. Bendszus, M.; Stoll, G. Caught in the act: in vivo mapping of macrophage infiltration in nerve injury by magnetic resonance imaging. J. Neurosci., 2003, 23, 10892-10896.
36. Ruehm, S.G.; Corot, C.; Vogt, P.; Kolb, S.; Debatin, J.F. Magnetic resonance imaging of atherosclerotic plaque with ultrasmall superparamagnetic particles of iron oxide in hyperlipidemic rabbits. Circulation, 2001, 103, 415-422.
37. Kooi, M.E.; Cappendijk, V.C.; Cleutjens, K.B.; Kessels, A.G.; Kitslaar, P.J.; Borgers, M.; Frederik, P.M.; Daemen, M.J.; van Engelshoven, J.M. Accumulation of ultrasmall superparamagnetic particles of iron oxide in human atherosclerotic plaques can be detected by in vivo magnetic resonance imaging. Circulation., 2003, 107, 2453-2458.
38. Hoehn, M.; Wiedermann, D.; Justicia, C.; Ramos-Cabrer, P.; Kruttwig, K.; Farr, T.; Himmelreich, U. Cell tracking using magnetic resonance imaging. J. Physiol., 2007, 584, 25-30.
39. Chang, N.K.; Jeong, Y.Y.; Park, J.S.; Jeong, H.S.; Jang, S.; Jang, M.J.; Lee, J.H.; Shin, S.S.; Yoon, W.; Chung, T.W.; Kang, H.K. Tracking of neural stem cells in rats with intracerebral hemorrhage by the use of 3T MRI. Korean J. Radiol., 2008, 9, 196-204.
40. Guzman, R.; Bliss, T.; De Los Angeles, A.; Moseley, M.; Palmer, T.; Steinberg, G. Neural progenitor cells transplanted into the uninjured brain undergo targeted migration after stroke onset. J. Neurosci. Res., 2008, 86, 873-882.
41. Arai, T.; Kofidis, T.; Bulte, J.W.; de Bruin, J.; Venook, R.D.; Berry, G.J.; McConnell, M.V.; Quertermous, T.; Robbins, R.C.; Yang, P.C. Dual in vivo magnetic resonance evaluation of magnetically labeled mouse embryonic stem cells and cardiac function at 1.5 t. Magn. Reson. Med., 2006, 55, 203-209.
42. Bos, C.; Delmas, Y.; Desmouliere, A.; Solanilla, A.; Hauger, O.; Grosset, C.; Dubus, I.; Ivanovic, Z.; Rosenbaum, J.; Charbord, P.; Combe, C.; Bulte, J.W.; Moonen, C.T.; Ripoche, J.; Grenier, N. In vivo MR imaging of intravascularly injected magnetically labeled mesenchymal stem cells in rat kidney and liver. Radiology, 2004, 233, 781-789.
43. Song, H.T.; Choi, J.S.; Huh, Y.M.; Kim, S.; Jun, Y.W.; Suh, J.S.; Cheon, J. Surface modulation of magnetic nanocrystals in the development of highly efficient magnetic resonance probes for intracellular labeling. J. Am. Chem. Soc., 2005, 127, 9992-9993.
44. Qiu, B.; Yang, X. Molecular MRI of hematopoietic stemprogenitor cells: in vivo monitoring of gene therapy and atherosclerosis. Nat. Clin. Pract. Cardiovasc. Med., 2008, 5, 396-404.
45. Gao, F.; Kar, S.; Zhang, J.; Qiu, B.; Walczak, P.; Larabi, M.; Xue, R.; Frost, E.; Qian, Z.; Bulte, J.W.; Yang, X. MRI of intravenously injected bone marrow cells homing to the site of injured arteries. NMR. Biomed., 2007, 20, 673-681.
46. Verdijk, P.; Scheenen, T.W.; Lesterhuis, W.J.; Gambarota, G.; Veltien, A.A.; Walczak, P.; Scharenborg, N.M.; Bulte, J.W.; Punt, C.J.; Heerschap, A.; Figdor, C.G.; de Vries, I.J. Sensitivity of magnetic resonance imaging of dendritic cells for in vivo tracking of cellular cancer vaccines. Int. J. Cancer, 2007, 120, 978-984.
47. Hoehn, M.; Kustermann, E.; Blunk, J.; Wiedermann, D.; Trapp, T.; Wecker, S.; Focking, M.; Arnold, H.; Hescheler, J.; Fleischmann, B.K.; Schwindt, W.; Buhrle, C. Monitoring of implanted stem cell migration in vivo: a highly resolved in vivo magnetic resonance imaging investigation of experimental stroke in rat. Proc. Natl. Acad. Sci. USA, 2002, 99, 16267-16272.
48. Magnitsky, S.; Watson, D.J.; Walton, R.M.; Pickup, S.; Bulte, J.W.; Wolfe, J.H.; Poptani, H. In vivo and ex vivo MRI detection of localized and disseminated neural stem cell grafts in the mouse brain. Neuroimage, 2005, 26, 744-754.
49. Dahnke, H.; Schaeffter, T. Limits of detection of SPIO at 3.0 T using T2 relaxometry. Magn. Reson. Med., 2005, 53, 1202-1206.
50. Foster-Gareau, P.; Heyn, C.; Alejski, A.; Rutt, B.K. Imaging single mammalian cells with a 1.5 T clinical MRI scanner. Magn. Reson. Med., 2003, 49, 968-971.
51. Heyn, C.; Ronald, J.A.; Mackenzie, L.T.; MacDonald, I.C.; Chambers, A.F.; Rutt, B.K.; Foster, P.J. In vivo magnetic resonance imaging of single cells in mouse brain with optical validation. Magn. Reson. Med., 2006, 55, 23-29.
52. Farrell, E.; Wielopolski, P.; Pavljasevic, P.; van Tiel, S.; Jahr, H.; Verhaar, J.; Weinans, H.; Krestin, G.; O'Brien, F.J.; van Osch, G.; Bernsen, M. Effects of iron oxide incorporation for long term cell tracking on MSC differentiation in vitro and in vivo. Biochem. Biophys. Res. Commun., 2008, 369, 1076-1081.
53. Guzman, R.; Uchida, N.; Bliss, T.M.; He, D.; Christopherson, K.K.; Stellwagen, D.; Capela, A.; Greve, J.; Malenka, R.C.; Moseley, M.E.; Palmer, T.D.; Steinberg, G.K. Long-term monitoring of transplanted human neural stem cells in developmental and pathological contexts with MRI. Proc. Natl. Acad. Sci. USA, 2007, 104, 10211-10216.
54. Wang, L.; Deng, J.; Wang, J.; Xiang, B.; Yang, T.; Gruwel, M.; Kashour, T.; Tomanek, B.; Summer, R.; Freed, D.; Jassal, D.S.; Dai, G.; Glogowski, M.; Deslauriers, R.; Arora, R.C.; Tian, G. Superparamagnetic iron oxide does not affect the viability and function of adipose-derived stem cells, and superparamagnetic iron oxide-enhanced magnetic resonance imaging identifies viable cells. Magn. Reson. Imaging, 2009, 27, 108-119.
55. Delcroix, G.J.; Jacquart, M.; Lemaire, L.; Sindji, L.; Franconi, F.; Le Jeune, J.J.; Montero-Menei, C.N. Mesenchymal and neural stem cells labeled with HEDP-coated SPIO nanoparticles: In vitro characterization and migration potential in rat brain. Brain. Res., 2008.
56. Sykova, E.; Jendelova, P. In vivo tracking of stem cells in brain and spinal cord injury. Prog. Brain. Res., 2007, 161, 367-383.
57. Weissleder, R.; Stark, D.D.; Engelstad, B.L.; Bacon, B.R.; Compton, C.C.; White, D.L.; Jacobs, P.; Lewis, J. Superparamagnetic iron oxide: pharmacokinetics and toxicity. AJR. Am. J. Roentgenol., 1989, 152, 167-173.
58. Anzai, Y.; Piccoli, C.W.; Outwater, E.K.; Stanford, W.; Bluemke, D.A.; Nurenberg, P.; Saini, S.; Maravilla, K.R.; Feldman, D.E.; Schmiedl, U.P.; Brunberg, J.A.; Francis, I.R.; Harms, S.E.; Som, P.M.; Tempany, C.M. Evaluation of neck and body metastases to nodes with ferumoxtran 10-enhanced MR imaging: phase III safety and efficacy study. Radiology, 2003, 228, 777-788.
59. Gupta, A.K.; Curtis, A.S. Surface modified superparamagnetic nanoparticles for drug delivery: interaction studies with human fibroblasts in culture. J. Mater. Sci. Mater. Med., 2004, 15, 493-496.
60. Lewin, M.; Carlesso, N.; Tung, C.H.; Tang, X.W.; Cory, D.; Scadden, D.T.; Weissleder, R. Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat. Biotechnol., 2000, 18, 410-414.
61. Mailander, V.; Lorenz, M.R.; Holzapfel, V.; Musyanovych, A.; Fuchs, K.; Wiesneth, M.; Walther, P.; Landfester, K.; Schrezenmeier, H. Carboxylated superparamagnetic iron oxide particles label cells intracellularly without transfection agents. Mol. Imaging Biol., 2008, 10, 138-146.
62. Arbab, A.S.; Bashaw, L.A.; Miller, B.R.; Jordan, E.K.; Lewis, B.K.; Kalish, H.; Frank, J.A. Characterization of biophysical and metabolic properties of cells labeled with superparamagnetic iron oxide nanoparticles and transfection agent for cellular MR imaging. Radiology, 2003, 229, 838-846.
63. Emerit, J.; Beaumont, C.; Trivin, F. Iron metabolism, free radicals, and oxidative injury. Biomed. Pharmacother., 2001, 55, 333-339.
64. Li, N.; Sioutas, C.; Cho, A.; Schmitz, D.; Misra, C.; Sempf, J.; Wang, M.; Oberley, T.; Froines, J.; Nel, A. Ultrafine particulate pollutants induce oxidative stress and mitochondrial damage. Environ. Health Perspect., 2003, 111, 455-460.
65. Thorek, D.L.; Tsourkas, A. Size, charge and concentration dependent uptake of iron oxide particles by non-phagocytic cells. Biomaterials, 2008, 29, 3583-3590.
66. Arbab, A.S.; Yocum, G.T.; Wilson, L.B.; Parwana, A.; Jordan, E.K.; Kalish, H.; Frank, J.A. Comparison of transfection agents in forming complexes with ferumoxides, cell labeling efficiency, and cellular viability. Mol. Imaging, 2004, 3, 24-32.
67. Park, I.K.; Ng, C.P.; Wang, J.; Chu, B.; Yuan, C.; Zhang, S.; Pun, S.H. Determination of nanoparticle vehicle unpackaging by MR imaging of a T(2) magnetic relaxation switch. Biomaterials, 2008, 29, 724-732.
68. Yoo, H.S.; Park, T.G. Folate-receptor-targeted delivery of doxorubicin nano-aggregates stabilized by doxorubicin-PEG-folate conjugate. J. Control. Release, 2004, 100, 247-256.
69. Hong, G.; Yuan, R.; Liang, B.; Shen, J.; Yang, X.; Shuai, X. Folate-functionalized polymeric micelle as hepatic carcinomatargeted, MRI-ultrasensitive delivery system of antitumor drugs. Biomed. Microdevices, 2008, 10, 693-700.
70. Clement, O.; Siauve, N.; Cuenod, C.A.; Frija, G. Liver imaging with ferumoxides (Feridex): fundamentals, controversies, and practical aspects. Top. Magn. Reson. Imaging, 1998, 9, 167-182.
71. McLachlan, S.J.; Morris, M.R.; Lucas, M.A.; Fisco, R.A.; Eakins, M.N.; Fowler, D.R.; Scheetz, R.B.; Olukotun, A.Y. Phase I clinical evaluation of a new iron oxide MR contrast agent. J. Magn. Reson. Imaging., 1994, 4, 301-307.
72. Reimer, P.; Marx, C.; Rummeny, E.J.; Muller, M.; Lentschig, M.; Balzer, T.; Dietl, K.H.; Sulkowski, U.; Berns, T.; Shamsi, K.; Peters, P.E. SPIO-enhanced 2D-TOF MR angiography of the portal venous system: results of an intraindividual comparison. J. Magn. Reson. Imaging, 1997, 7, 945-949.
73. Simon, G.H.; von Vopelius-Feldt, J.; Fu, Y.; Schlegel, J.; Pinotek, G.; Wendland, M.F.; Chen, M.H.; Daldrup-Link, H.E. Ultrasmall supraparamagnetic iron oxide-enhanced magnetic resonance imaging of antigen-induced arthritis: a comparative study between SHU 555 C, ferumoxtran-10, and ferumoxytol. Invest. Radiol., 2006, 41, 45-51.
74. Li, W.; Tutton, S.; Vu, A.T.; Pierchala, L.; Li, B.S.; Lewis, J.M.; Prasad, P.V.; Edelman, R.R. First-pass contrast-enhanced magnetic resonance angiography in humans using ferumoxytol, a novel ultrasmall superparamagnetic iron oxide (USPIO)-based blood pool agent. J. Magn. Reson. Imaging, 2005, 21, 46-52.
75. Hahn, P.F.; Stark, D.D.; Lewis, J.M.; Saini, S.; Elizondo, G.; Weissleder, R.; Fretz, C.J.; Ferrucci, J.T. First clinical trial of a new superparamagnetic iron oxide for use as an oral gastrointestinal contrast agent in MR imaging. Radiology, 1990, 175, 695-700.
76. Wagner, S.; Schnorr, J.; Pilgrimm, H.; Hamm, B.; Taupitz, M. Monomer-coated very small superparamagnetic iron oxide particles as contrast medium for magnetic resonance imaging: preclinical in vivo characterization. Invest. Radiol., 2002, 37, 167-177.
77. Turetschek, K.; Huber, S.; Helbich, T.; Floyd, E.; Tarlo, K.S.; Roberts, T.P.; Shames, D.M.; Wendland, M.F.; Brasch, R.C. Dynamic MRI enhanced with albumin-(Gd-DTPA)30 or ultrasmall superparamagnetic iron oxide particles (NC100150 injection) for the measurement of microvessel permeability in experimental breast tumors. Acad. Radiol., 2002, 9(Suppl 1), S112-4.
78. Delcroix, G.J.; Jacquart, M.; Lemaire, L.; Sindji, L.; Franconi, F.; Le Jeune, J.J.; Montero-Menei, C.N. Mesenchymal and neural stem cells labeled with HEDP-coated SPIO nanoparticles: in vitro characterization and migration potential in rat brain. Brain Res., 2009, 1255, 18-31.
79. Zhang, Z.; van den Bos, E.J.; Wielopolski, P.A.; de Jong-Popijus, M.; Bernsen, M.R.; Duncker, D.J.; Krestin, G.P. In vitro imaging of single living human umbilical vein endothelial cells with a clinical 3.0-T MRI scanner. MAGMA, 2005, 18, 175-185.
80. Pisanic, T.R., 2nd; Blackwell, J.D.; Shubayev, V.I.; Finones, R.R.; Jin, S. Nanotoxicity of iron oxide nanoparticle internalization in growing neurons. Biomaterials., 2007, 28, 2572-2581.
81. Hsiao, J.K.; Chu, H.H.; Wang, Y.H.; Lai, C.W.; Chou, P.T.; Hsieh, S.T.; Wang, J.L.; Liu, H.M. Macrophage physiological function after superparamagnetic iron oxide labeling. NMR. Biomed., 2008, 21, 820-829.
82. Hussain, S.M.; Hess, K.L.; Gearhart, J.M.; Geiss, K.T.; Schlager, J.J. In vitro toxicity of nanoparticles in BRL 3A rat liver cells. Toxicol. In Vitro, 2005, 19, 975-983.
83. Schafer, R.; Kehlbach, R.; Wiskirchen, J.; Bantleon, R.; Pintaske, J.; Brehm, B.R.; Gerber, A.; Wolburg, H.; Claussen, C.D.; Northoff, H. Transferrin receptor upregulation: in vitro labeling of rat mesenchymal stem cells with superparamagnetic iron oxide. Radiology, 2007, 244, 514-523.
84. Huang, D.M.; Hsiao, J.K.; Chen, Y.C.; Chien, L.Y.; Yao, M.; Chen, Y.K.; Ko, B.S.; Hsu, S.C.; Tai, L.A.; Cheng, H.Y.; Wang, S.W.; Yang, C.S.; Chen, Y.C. The promotion of human mesenchymal stem cell proliferation by superparamagnetic iron oxide nanoparticles. Biomaterials, 2009, 30, 3645-3651.
85. Mahmoudi, M.; Simchi, A.; Milani, A.S.; Stroeve, P. Cell toxicity of superparamagnetic iron oxide nanoparticles. J Colloid Interface Sci., 2009, 336, 510-518.
86. Karlsson, H.L.; Gustafsson, J.; Cronholm, P.; Möller, L. Sizedependent toxicity of metal oxide particles-A comparison between nano-and micrometer size. Toxicol. Lett., 2009, 188, 112-118.
87. Schäfer, R.; Kehlbach, R.; Müller, M.; Bantleon, R.; Kluba, T.; Ayturan, M.; Siegel, G.; Wolburg, H.; Northoff, H.; Dietz, K.; Claussen, C.D.; Wiskirchen, J. Labeling of human mesenchymal stromal cells with superparamagnetic iron oxide leads to a decrease in migration capacity and colony formation ability. Cytotherapy, 2009, 11, 68-78.